Monash IVF Group Limited

Equities

MVF

AU000000MVF3

Healthcare Facilities & Services

Delayed Australian S.E. 01:52:22 2024-05-01 am EDT 5-day change 1st Jan Change
1.455 AUD -0.68% Intraday chart for Monash IVF Group Limited -3.96% +11.92%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 MT
RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 MT
Monash IVF Group Limited(ASX:MVF) added to S&P/ASX Small Ordinaries Index CI
Monash IVF Group Limited(ASX:MVF) added to S&P/ASX 300 Index CI
Morgan Stanley Adjusts Monash IVF Group’s Price Target to AU$1.65 From AU$1.45, Keeps at Overweight MT
Monash IVF Group Completes Fertility North Acquisition MT
Monash IVF Group Limitedcompleted the acquisition of 80% stake in Fertility North Holdings Pty Ltd. CI
Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024 CI
Monash IVF Group Shares Fall 3% Despite EPS Growth in H1 FY24 on 22% Revenue Jump MT
Transcript : Monash IVF Group Limited, H1 2024 Earnings Call, Feb 23, 2024
Monash IVF Group Reports H1 FY24 Revenue Up 22% to AU$125.7 Million; EPS of AU$0.033 MT
Monash IVF Reports Half Year FY24 Revenue Up 21.7% to AU$125.7 Million; EPS of AU$0.033 MT
Monash IVF Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Competition Regulator Clears Monash IVF Group's Acquisition of Fertility North MT
Monash Ivf Group Acquiring Perth-based Fertility Services Provider MT
Monash IVF Group Limited entered into Share Sale Agreement to acquire 80% stake in Fertility North Holdings Pty Ltd. CI
Transcript : Monash IVF Group Limited - Shareholder/Analyst Call
Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023 CI
Monash IVF Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Monash IVF Group Limited completed the acquisition of PIVET Medical Centre. CI
Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended December 31, 2022, Payable on April 7, 2023 CI
Monash IVF Group Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Transcript : Monash IVF Group Limited - Shareholder/Analyst Call
Monash IVF Acquires ART Associates Queensland MT
Monash IVF Group Limited completed the acquisition of ART Associates Queensland #2 Pty Ltd. CI
Chart Monash IVF Group Limited
More charts
Monash IVF Group Limited is an Australia-based company, which is primarily involved in assisted reproductive services. The Company is also a provider of specialist women’s imaging services. It operates through two segments: Monash IVF Group Australia and Monash IVF Group International. The Monash IVF Group Australia segment provides assisted reproductive services, ultrasound, and other related services. The Monash IVF Group International segment provides assisted reproductive services in Southeast Asia. The Company's business includes Fertility Solutions that provide fertility treatment and care; KL Fertility is a fertility specialist center; Monash IVF is a fertility research and treatment center; Monash IVF KPJ Johor is a full-service hospital-based fertility center, and Monash Ultrasound for Women provides tertiary level prenatal diagnostic services. Its business also includes Repromed and Sydney Ultrasound for Women.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.465 AUD
Average target price
1.541 AUD
Spread / Average Target
+5.17%
Consensus
  1. Stock Market
  2. Equities
  3. MVF Stock
  4. News Monash IVF Group Limited
  5. Monash IVF Reports Half Year FY24 Revenue Up 21.7% to AU$125.7 Million; EPS of AU$0.033